ArrowMark Colorado Holdings LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
ArrowMark Colorado Holdings LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$176,356
-31.7%
15,9310.0%0.00%
-33.3%
Q2 2023$258,242
-2.6%
15,9310.0%0.00%0.0%
Q1 2023$265,251
+77.1%
15,9310.0%0.00%
+50.0%
Q4 2022$149,751
+248.3%
15,9310.0%0.00%
+100.0%
Q3 2022$43,000
-12.2%
15,931
-5.9%
0.00%0.0%
Q2 2022$49,000
-9.3%
16,931
-6.4%
0.00%
Q1 2022$54,000
-99.8%
18,081
-99.7%
0.00%
-100.0%
Q4 2021$32,480,000
-35.3%
7,060,803
-11.7%
0.26%
-33.8%
Q3 2021$50,197,000
+9.2%
7,993,211
+4.2%
0.39%
+13.6%
Q2 2021$45,947,000
-5.0%
7,670,552
+0.3%
0.35%
-4.4%
Q1 2021$48,379,000
+1.0%
7,648,852
-10.1%
0.36%
-2.4%
Q4 2020$47,899,000
+3.0%
8,507,790
+6.5%
0.37%
-16.3%
Q3 2020$46,494,000
-23.8%
7,988,635
-5.6%
0.44%
-29.7%
Q2 2020$61,017,000
+47.7%
8,462,833
-4.1%
0.63%
+16.2%
Q1 2020$41,299,000
-41.6%
8,824,526
+0.1%
0.54%
-13.8%
Q4 2019$70,685,000
+26.3%
8,813,578
+8.4%
0.63%
+12.7%
Q3 2019$55,945,000
-1.6%
8,131,528
+18.7%
0.56%
+2.0%
Q2 2019$56,864,000
+27.1%
6,851,093
+52.3%
0.55%
+29.9%
Q1 2019$44,722,000
+53.9%
4,499,204
+18.5%
0.42%
+38.0%
Q4 2018$29,050,000
-41.9%
3,797,336
+32.3%
0.30%
-27.2%
Q3 2018$50,014,000
+205.7%
2,871,087
+66.5%
0.42%
+179.3%
Q2 2018$16,361,000
+129.9%
1,723,982
+5.8%
0.15%
+111.3%
Q1 2018$7,118,0001,628,7510.07%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders